Buyback Spend for Merck & Co. (MRK)
Buyback Spend for Merck & Co. (MRK): headline value $6.25B · YoY +289.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRK
Currently viewingBuyback SpendSwitch metric
Latest period
$6.25B
YoY change
+289.3%
5Y CAGR
+31.7%
Peak year (2018)
$9.09B
Latest annual
$5.08B
Buyback Spend history chart for Merck & Co. (MRK) from 1989 to 2025
Buyback Spend history table for Merck & Co. (MRK) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $5.08B | +289.3% | ||
| 2024 | $1.31B | -3.0% | ||
| 2023 | $1.35B | — | ||
| 2022 | $0 | -100.0% | ||
| 2021 | $840.00M | -34.4% | ||
| 2020 | $1.28B | -73.2% | ||
| 2019 | $4.78B | -47.4% | ||
| 2018 | $9.09B | +126.5% | ||
| 2017 | $4.01B | +16.9% | ||
| 2016 | $3.43B | -18.0% | ||
| 2015 | $4.19B | -45.7% | ||
| 2014 | $7.70B | +18.2% | ||
| 2013 | $6.52B | +151.5% | ||
| 2012 | $2.59B | +34.9% | ||
| 2011 | $1.92B | +20.6% | ||
| 2010 | $1.59B | — | ||
| 2009 | $0 | -100.0% | ||
| 2008 | $2.73B | +90.6% | ||
| 2007 | $1.43B | +42.6% | ||
| 2006 | $1.00B | -1.3% | ||
| 2005 | $1.02B | -59.0% | ||
| 2004 | $2.47B | +21.7% | ||
| 2003 | $2.03B | -2.7% | ||
| 2002 | $2.09B | -46.3% | ||
| 2001 | $3.89B | +9.7% | ||
| 2000 | $3.55B | -1.0% | ||
| 1999 | $3.58B | -1.2% | ||
| 1998 | $3.63B | +1.5% | ||
| 1997 | $3.57B | +43.3% | ||
| 1996 | $2.49B | +58.7% | ||
| 1995 | $1.57B | +123.0% | ||
| 1994 | $704.50M | +89.9% | ||
| 1993 | $371.00M | -57.0% | ||
| 1992 | $862.90M | +368.7% | ||
| 1991 | $184.10M | -75.3% | ||
| 1990 | $744.80M | +257.7% | ||
| 1989 | $208.20M | — |
Buyback Spend values are taken from Merck & Co.'s reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Merck & Co. (MRK) reported buyback spend of $5.08B – surged 289.3% year-over-year.
Over 2020–2025 (5 years), Merck & Co. buyback spend expanded at a +31.7% compound annual rate, with the latest reading among the more recent periods of the dataset.
Merck & Co. buyback spend peaked at $9.09B in 2018; the latest annual figure is $5.08B in 2025 (44.1% below peak).
2018 marks the peak buyback spend at $9.09B, with the historical low of $0 recorded in 2009.
Among 8 Healthcare peers, Merck & Co. (MRK) ranks 3rd; the peer median for buyback spend is $2.19B.
Merck & Co. Buyback Spend by Year
Merck & Co. Buyback Spend 2025: $5.08B
Merck & Co. buyback spend in 2025 was $5.08B, surged 289.3% from 2024.
Merck & Co. Buyback Spend 2024: $1.31B
Merck & Co. buyback spend in 2024 was $1.31B, edged down 3.0% below 2023.
Merck & Co. Buyback Spend 2023: $1.35B
Merck & Co. buyback spend in 2023 was $1.35B.
Merck & Co. Buyback Spend 2022: $0
Merck & Co. buyback spend in 2022 was $0, plunged 100.0% below 2021.
Merck & Co. Buyback Spend 2021: $840.00M
Merck & Co. buyback spend in 2021 was $840.00M.
See more financial history for Merck & Co. (MRK).
Sector peers — Buyback Spend
Companies in the same sector as Merck & Co., ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $3.00B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Merck & Co.'s buyback spend?
Latest reported buyback spend for Merck & Co. (MRK) is $6.25B (period ending December 31, 2025).
How has Merck & Co. buyback spend changed year-over-year?
Merck & Co. (MRK) buyback spend changed +289.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Merck & Co. buyback spend?
Merck & Co. (MRK) buyback spend compound annual growth rate is +31.7% over the most recent 5 years available.
When did Merck & Co. buyback spend hit its highest annual value?
Merck & Co. buyback spend reached its highest annual value of $9.09B in 2018.
What was Merck & Co. buyback spend in 2024?
Merck & Co. (MRK) buyback spend in 2024 was $1.31B.
What was Merck & Co. buyback spend in 2025?
Merck & Co. (MRK) buyback spend in 2025 was $5.08B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
MRK Overview
Company profile, financial tools, and key metrics
MRK Revenue Counter
Earns $2,061 every second. See per minute, hour, and day.
MRK Earnings Counter
Earns $578.83 per second net profit. See per minute, hour, and day.
MRK Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
MRK What If Invested
What if you had invested $1,000? See historical returns from any date.
MRK How It Makes Money
Discover visual breakdown of $65.01B in revenue — where it comes from and where it goes.
MRK Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRK Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRK Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
MRK Buybacks
2.39% TTM buyback yield. Shareholder yield & SBC comparison.
MRK Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MRK Dividend Profile
Yield: 2.99%. Safety: 8/8. See full history.
MRK Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MRK Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.